Yingjie Guo

Also affiliated with Jilin University, Jilin Jianzhu University, Affiliated Hospital of Qingdao University, Palo Alto Institute, Arc Research Institute

MedicinePharmacology, Toxicology and PharmaceuticsImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy”.

Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy

Epilepsy Research(2013)10.1016/j.eplepsyres.2013.09.011

N/A

0.524DataRank · unranked

32 citations

Feng Zhang, Cheng Hu, Xiaopei Luo, Peng Xue, Jing Wang +4 more

ENPP1 inhibitor with ultralong drug-target residence time as an innate immune checkpoint blockade cancer therapy

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102336

N/A

0DataRank · unranked

5 citations

Randolph M. Johnson, Jacqueline A. Carozza, Daniel Fernández, Jan Scicinski, Neil A. Verity +7 more